Novan rallies 57% after Nitricil shows encouraging in vitro effect against COVID-19

Novan (NASDAQ:NOVN) surges 57% premarket after announcing positive in vitro results showing the potential efficacy of its NITRICIL platform technology as an antiviral against SARS-CoV-2.
The Company… [read more]

Leave a Comment